374881
4-Chloro-3-(trifluoromethyl)phenyl isocyanate
98%
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
ClC6H3(CF3)NCO
CAS Number:
Molecular Weight:
221.56
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
MDL number:
Assay:
98%
Quality Level
assay
98%
bp
86-90 °C/14 mmHg (lit.)
mp
40-42 °C (lit.)
functional group
chloro, fluoro, isocyanate
SMILES string
FC(F)(F)c1cc(ccc1Cl)N=C=O
InChI
1S/C8H3ClF3NO/c9-7-2-1-5(13-4-14)3-6(7)8(10,11)12/h1-3H
InChI key
NBJZEUQTGLSUOB-UHFFFAOYSA-N
General description
4-Chloro-3-(trifluoromethyl)phenyl isocyanate participates in an efficient methodology for the synthesis of 5-methyl-3-aryl-2-thiooxazolidin-4-ones.
Application
4-Chloro-3-(trifluoromethyl)phenyl isocyanate may be used in the synthesis of:
- N-(5′-deoxy-3′-O-tert-butyldimethylsilyl-β-D-thymidin-5′-yl)-N′-(4-chloro-3-trifluoromethylphenyl)-thiourea
- [1,3-bis(4-chloro-α,α,α-trifluoro-m-tolyl)urea]
- trans-1-(4-chloro-3-trifluoromethyl-phenyl)-3-(4-hydroxy-cyclohexyl)-urea
signalword
Danger
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Dam. 1 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
target_organs
Respiratory system
Storage Class
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
210.2 °F - closed cup
flash_point_c
99 °C - closed cup
ppe
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Hiromi I Wettersten et al.
Cancer biology & therapy, 14(3), 278-285 (2013-01-10)
p21 is a member of the cyclin kinase inhibitor family of proteins and plays pivotal roles in cellular proliferation as well as in the regulation of apoptosis, and thus has diverse functions in diseases as varied as cancer and atherosclerosis.
Sung Hee Hwang et al.
Bioorganic & medicinal chemistry letters, 23(13), 3732-3737 (2013-06-04)
To reduce the pro-angiogenic effects of sEH inhibition, a structure-activity relationship (SAR) study was performed by incorporating structural features of the anti-angiogenic multi-kinase inhibitor sorafenib into soluble epoxide hydrolase (sEH) inhibitors. The structural modifications of this series of molecules enabled
Extraction and determination of the Mitins sulcofuron and flucofuron from environmental river water.
aM Hancock P.
Analyst, 123(8), 1669-1674 (1998)
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 374881-5G | 04061836826642 |